Medivation - Articles and news items

Medivation’s Board

Medivation in confidentiality agreements with Sanofi and others

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Medivation has entered into confidentiality agreements with parties that have expressed interest in exploring a potential transaction to acquire the company…

Pidilizumab shows potential clinical benefit in children with DIPG

Industry news / 16 June 2016 / Victoria White, Digital Content Producer

Results from a Phase I/II study of pidilizumab demonstrated potential clinical benefit in paediatric patients with diffuse intrinsic pontine glioma (DIPG)…

Medivation’s Board

Sanofi files consent solicitation to replace Medivation’s Board

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Sanofi says it had ‘no choice’ but to commence a process to elect eight independent directors who are more open to evaluating Sanofi’s takeover proposal…

Medivation’s Board

Medivation’s Board rejects Sanofi’s unsolicited proposal

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

Medivation’s Board has determined that the proposal from Sanofi to acquire Medivation for $52.50 per share substantially undervalues the company…

Medivation’s Board

Sanofi makes $9.3b offer to acquire Medivation

Industry news / 28 April 2016 / Victoria White, Digital Content Producer

Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi…

Phase III enzalutamide trial initiated in mHSPC

Industry news / 29 March 2016 / Victoria White

The ARCHES trial will evaluate the efficacy and safety of enzalutamide with androgen deprivation therapy (ADT) versus placebo with ADT in mHSPC patients…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+